GWSG
ACXP icon

GPS Wealth Strategies Group’s Acurx Pharmaceuticals ACXP Stock Holding History

GPS Wealth Strategies Group’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,225
Closed -$5.26K – 594
2025
Q3 		$5.26K Buy
1,225
+50
+4% +$301 ﹤0.01% 1250
2025
Q2 		$12K Buy
1,175
+1,150
+4,600% +$9.26K ﹤0.01% 985
2025
Q1 		$195 Hold
25
– – ﹤0.01% 1432
2024
Q4 		$407 Hold
25
– – ﹤0.01% 1333
2024
Q3 		$950 Hold
25
– – ﹤0.01% 1294
2024
Q2 		$1.13K Hold
25
– – ﹤0.01% 1250
2024
Q1 		$1.23K Hold
25
– – ﹤0.01% 1156
2023
Q4 		$1.92K Buy
+25
New +$1.89K ﹤0.01% 1121

Other funds holding ACXP

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

GPS Wealth Strategies Group's ACXP Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Acurx Pharmaceuticals (ACXP) in Q4 2025, closing a stake of 1,225 shares — an estimated $5.26K sold.

GPS Wealth Strategies Group first reported a position in ACXP in Q4 2023 and held it in 8 quarters. The position peaked at $12K in Q2 2025. 18 funds tracked by Wall St. Rank hold ACXP as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Acurx Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 1,225 Acurx Pharmaceuticals shares in Q4 2025, an estimated $5.26K.
  • GPS Wealth Strategies Group first reported a position in Acurx Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • GPS Wealth Strategies Group's Acurx Pharmaceuticals position peaked at $12K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.